Mon, Aug 20, 2012 6:20 pm
Northeastern Section American Chemical Society
The 925th Meeting of the
of the American ChemicalSociety
Thursday, September 13, 2012to be held at
Holiday Inn Select/Woburn
15 Middlesex Canal Park, Woburn 01801
"Globalization of Japanese Pharmaceutical Industry
Strategies, Innovations, and FutureTrends"
Eisai CO., Ltd.
Dr. Kenichi Nomoto, President, Oncology Product Creation Unit
Millennium Pharmaceuticals, The TAKEDA Oncology Company
Kyle D. Kuvalanka, Vice President, Corporate Strategy and Development
RaQualia Pharmaceuticals Inc
. Dr. Atsushi Nagahisa, President & CEO
Astellas Pharmaceuticals Inc.
Dr. Eiichiro Suzuki, Executive Fellow
H3 Biomedicine Inc.
Dr. Peter Smith, Executive Director of Target Biology
Cardiff University, UK
Dr. Maki Umemura,
Dainippon Sumitomo Pharmaceuticals Inc.
TBD *****Please check the NESACS website (http://www.nesacs.org/)for program details *****
Dr. Ruth Tanner, Chair, NESACS
Dr. Maki Umemura, Cardiff University, UK"
Crisis and change in the system of innovation: the Japanese pharmaceutical industry since the 1990s"
Registration and Fees
1 of 28/21/2012 9:30 AM